DK221281A - Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber

Info

Publication number
DK221281A
DK221281A DK221281A DK221281A DK221281A DK 221281 A DK221281 A DK 221281A DK 221281 A DK221281 A DK 221281A DK 221281 A DK221281 A DK 221281A DK 221281 A DK221281 A DK 221281A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
pharmaceutical preparation
improved release
release features
Prior art date
Application number
DK221281A
Other languages
English (en)
Inventor
C B Bogentoft
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20341009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK221281(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK221281A publication Critical patent/DK221281A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DK221281A 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber DK221281A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Publications (1)

Publication Number Publication Date
DK221281A true DK221281A (da) 1981-11-22

Family

ID=20341009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK221281A DK221281A (da) 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber

Country Status (9)

Country Link
EP (1) EP0040590A3 (da)
DK (1) DK221281A (da)
ES (1) ES502345A0 (da)
GR (1) GR75634B (da)
NO (1) NO811721L (da)
PH (1) PH16539A (da)
PT (1) PT73065B (da)
SE (1) SE8003805L (da)
ZA (1) ZA813017B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (da) * 1980-03-20 1982-03-11
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
ATE124864T1 (de) * 1989-03-10 1995-07-15 Yamanouchi Pharma Co Ltd Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen.
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE29502547U1 (de) * 1995-02-16 1995-03-30 Roehm Gmbh Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
AU2546399A (en) 1998-02-10 1999-08-30 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
NZ513037A (en) 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
WO2003096874A2 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
BRPI0509331B8 (pt) 2004-03-30 2021-05-25 Ilypsa Inc uso de uma composição de ligação de sódio
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
AU2005271193B2 (en) * 2004-08-13 2011-11-24 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
HUE043474T2 (hu) * 2008-01-10 2019-08-28 Evonik Roehm Gmbh Bevont gyógyszerészeti vagy gyógyhatású étrend-kiegészítõ készítmény javított pulzáló hatóanyag-felszabadulással
EP2231122A1 (en) * 2008-01-10 2010-09-29 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
CN102238868A (zh) 2008-10-03 2011-11-09 福尔克博士药物有限责任公司 使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
FR3102931B1 (fr) 2019-11-13 2021-12-24 Ethypharm Sa Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique
WO2021094697A1 (fr) 2019-11-13 2021-05-20 Ethypharm Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1297719A (da) * 1970-06-11 1972-11-29
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung

Also Published As

Publication number Publication date
ES8301630A1 (es) 1982-12-16
GR75634B (da) 1984-08-01
EP0040590A3 (en) 1983-01-12
EP0040590A2 (en) 1981-11-25
PT73065A (en) 1981-06-01
PT73065B (en) 1983-02-08
NO811721L (no) 1981-11-23
SE8003805L (sv) 1981-11-22
ZA813017B (en) 1982-05-26
PH16539A (en) 1983-11-10
ES502345A0 (es) 1982-12-16

Similar Documents

Publication Publication Date Title
DK221281A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber
DK151608C (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK158282C (da) Fremgangsmaade til fremstilling af et fast fibrinogenpraeparat
DK195083D0 (da) Fremgangsmade til fremstilling af et glaucomapraeparat
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK271677A (da) Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
DK153773C (da) Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel
DK345081A (da) Fremgangsmaade til fremstilling af et stabilt vandigt praeparat indeholdende invermectin
DK154282A (da) Fremgangsmaade til fremstilling af et varmeisoleret ledningsroer
DK160739C (da) Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK528879A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
DK476180A (da) Fremgangsmaade til fremstilling af tabletter
NO810062L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig frigjoering
DK1584A (da) Fremgangsmaade til fremstilling af et gitterkernesandwichelement
DK146482C (da) Fremgangsmaade til fremstilling af et b30-threonin-insulin
DK203879A (da) Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK155082A (da) Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning
DK494381A (da) Veterinaer-praeparat og fremgangsmaade til fremstilling af et macrolid
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK136481A (da) Fremgangsmaade til fremstilling af et insulinforstadium
DK275083D0 (da) Fremgangsmade til fremstilling af et pyrazolopyridinderivat
DK148636C (da) Fremgangsmaade til fremstilling af et lagringsbestandigt braendsel
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat

Legal Events

Date Code Title Description
ATS Application withdrawn